Free shipping on all orders over $ 500

MLN9708

Cat. No. M2122

All AbMole products are for research use only, cannot be used for human consumption.

MLN9708 Structure
Synonym:

ixazomib citrate

Size Price Availability Quantity
5mg USD 48 In stock
10mg USD 65 In stock
50mg USD 145 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

MLN9708 is a selective, orally bioavailable, second-generation proteasome inhibitor. MLN9708 has a shorter proteasome dissociation half-life and improved pharmacokinetics, pharmacodynamics, and antitumor activity compared with bortezomib. MLN9708 has a larger blood volume distribution at steady state, and analysis of 20S proteasome inhibition and markers of the unfolded protein response confirmed that MLN9708 has greater pharmacodynamic effects in tissues than bortezomib. MLN9708 showed activity in both solid tumor and hematologic preclinical xenograft models.

Another CAS# 1201902-80-8

Chemical Information
Molecular Weight 517.12
Formula C20H23BCl2N2O9
CAS Number 1239908-20-3
Solubility (25°C) DMSO: ≥ 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Lee EC, et al. Clin Cancer Res. Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies.

[2] Chauhan D, et al. Clin Cancer Res. In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells.

[3] Kupperman E, et al. Cancer Res. Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer.

Related Proteasome Products
Bortezomib (PS-341)

Bortezomib (PS-341) is a highly selective proteasome inhibitor with a ki value of 6nM.

CTP-518

CTP-518 is a novel HIV protease inhibitor. CTP-518 has the potential to be the first HIV protease inhibitor toeliminate the need to co-dose with a boosting agent.

ITMN-191

ITMN-191 (Danoprevir, RG7227) is a potent and orally active inhibitor of hepatitis C virus (HCV) NS3/4A serine protease with an IC50 of 1.6 nM.

MG132

MG132 is a specific and potent cell-permeable proteasome inhibitor (IC50 = 100 nM, Ki = 4 nM). MG-132 effectively blocks the proteolytic activity of the 26S proteasome complex. MG-132 is also a calpain inhibitor with IC50 of 1.2 μM.

IU1

IU1 is a reversible, small molecule inhibitor of deubiquitination by USP14 that demonstrates an IC50 value of 4-5 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: MLN9708, ixazomib citrate supplier, Proteasome, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.